Microwave Ablation Stocks
Precision medical technology developers and component manufacturers in this space focus on the application of high-frequency electromagnetic energy to induce thermal tissue destruction for oncology and cardiology interventions. Revenue models are driven by a mix of high-margin capital equipment sales and recurring revenue from specialized single-use probes and catheters.
As of Oct 23, 2026, Microwave Ablation has 2 US-listed companies worth $497M combined. The median member moved -5.6% over the past week; ANGO led at +10.0% and BDMD trailed at -21.3%.